amphotericin-b and Gastroenteritis

amphotericin-b has been researched along with Gastroenteritis* in 4 studies

Trials

1 trial(s) available for amphotericin-b and Gastroenteritis

ArticleYear
[Use of selective intestinal decontamination with non-absorbable antibiotics].
    Zeitschrift fur Gastroenterologie, 1995, Volume: 33, Issue:11

    Topics: Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Colistin; Cross Infection; Double-Blind Method; Gastroenteritis; Humans; Intestinal Mucosa; Tobramycin

1995

Other Studies

3 other study(ies) available for amphotericin-b and Gastroenteritis

ArticleYear
Development of nalidixic acid amphotericin B vancomycin (NAV) medium for the isolation of Campylobacter ureolyticus from the stools of patients presenting with acute gastroenteritis.
    British journal of biomedical science, 2014, Volume: 71, Issue:1

    Recently, Campylobacter ureolyticus has been detected for the first time in the faeces of patients with acute gastroenteritis using polymerase chain reaction (PCR) techniques. Cultural isolation of C. ureolyticusis is not possible using the established selective methods for the isolation of thermophilic Campylobacter spp. from faeces. The aim of the current study is to develop a new selective medium capable of isolating C. ureolyticus from faecal samples. The newly-developed medium consists of Anaerobe Basal Agar with 10 g/L additional agar, 2 g/L sodium formate and 3 g/L sodium fumarate dibasic, to which 10 mg/L nalidixic acid, 10 mg/L amphotericin B and 20 mg/L vancomycin (NAV) are added as selective agents. Validation studies have shown that this experimental selective medium completely inhibits growth of Candida spp. and of Enterococcus spp. and permits reduced growth of selected coliforms and Proteus spp. Growth of Campylobacter ureolyticus on NAV medium is optimal in anaerobic and enriched hydrogen atmospheres. Additionally, an overnight enrichment step using Bolton broth to which 2 g/L sodium formate, 3 g/L sodium fumarate dibasic and the NAV supplement are added, in place of the commercial Bolton broth supplement, allows improved recovery of C. ureolyticus from patients' faeces.

    Topics: Amphotericin B; Campylobacter; Culture Media; Feces; Gastroenteritis; Humans; Nalidixic Acid; Vancomycin

2014
Gastrointestinal mucormycoses in infants and children: a cause of gangrenous intestinal cellulitis and perforation.
    Journal of pediatric surgery, 1980, Volume: 15, Issue:3

    Gastrointestinal mucormycosis has been a uniformly fatal disease in children. Diagnosis has been difficult, resulting in inadequate therapy. Histologic and bacteriologic confirmation of invasive infection, followed by systemically administered amphotericin B and surgical excision, are the hallmarks of effective treatment.

    Topics: Amphotericin B; Appendicitis; Child; Gastroenteritis; Humans; Infant, Newborn; Mucormycosis; Stomach

1980
[Candidiasis].
    Medizinische Klinik, 1972, Sep-29, Volume: 67, Issue:39

    Topics: Amphotericin B; Candida albicans; Candidiasis; Candidiasis, Oral; Central Nervous System Diseases; Culture Media; Digestive System; Female; Gastroenteritis; Gentian Violet; Humans; Infant, Newborn; Mustard Compounds; Nystatin; Urinary Tract Infections

1972